Compare Incept Biosystems vs Innovate Technologies In Biological System
Customers evaluate the quality of Incept Biosystems's products using the following success metrics.
Overview
Incept Biosystems is 19 yrs old and is based in United States.
Incept BioSystems aims to develop nanoscale technologies that provide cell biologists the ability to obtain high value data about cell growth and behavior. Their technologies were developed to improve the in vitro manipulation, performance and viability for Premium Cell Management applications. On January 12, 2011, Incept BioSystems was acquired by ORIGIO. The terms of the transaction were not disclosed.
Innovate Technologies In Biological System is based in Spain
Innoprot tGFP-BACE1 HEK293 Cell Line CB2 Internalization Assay Cell Line hGR Nuclear Translocation Assay Cell Line Human Cardiac Myocytes Assay Development Neurotoxicity Assay induced by beta amyloid NEWS Innoprot has been awarded on the Bizkaia Ekinez Prizes 05/06/2009 Innoprot has been awarded on the Bizkaia Ekinez Prizes with the "Gaztedi Prize"
Demo Video
Leadership
Christopher A Bleck (Chief Executive Officer)
Clarisa Salado (Managing Director, Owner)
Investors
ORIGIO, Grand Angels
Seed Capital Bizkaia
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Incept Biosystems has not claimed their profile.
Work for Incept Biosystems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Incept Biosystems?
Claim your profile now.
Information not available because Innovate Technologies In Biological System has not claimed their profile.
Work for Innovate Technologies In Biological System? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Innovate Technologies In Biological System?
Claim your profile now.